(Q41854078)

English

Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide

scientific article published on 25 November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide (English)

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

0 references

myelodysplastic syndrome

1 reference

based on heuristic

inferred from title

Brigitte Schlegelberger

8

object named as

Brigitte Schlegelberger

0 references

6

object named as

Pierre Fenaux

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Aristoteles A N Giagounidis

2

object named as

Aristoteles Giagounidis

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Gudrun Göhring

1

object named as

Gudrun Göhring

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

author name string

Guntram Büsche

3

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Winfried Hofmann

4

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Hans Heinrich Kreipe

5

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Eva Hellström-Lindberg

7

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

25 November 2010

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

96

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

2

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

319-322

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031702

5 June 2018

Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031702

5 June 2018

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031702

5 June 2018

Cytogenetic evolution correlates with poor prognosis in myelodysplastic syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031702

18 August 2018

Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031702

18 August 2018

Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031702

18 August 2018

Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031702

18 August 2018

International Working Group on MDS cytogenetics: October 2007 meeting report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031702

18 August 2018

Cytogenetic and fluorescence in situ hybridization monitoring in Ph+ Chronic Myeloid Leukemia patients treated with imatinib mesylate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031702

18 August 2018

Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031702

18 August 2018

Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031702

18 August 2018

Primary myelodysplastic syndrome with normal cytogenetics: utility of 'FISH panel testing' and M-FISH.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031702

18 August 2018

Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21109690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies wit

1 reference

https://pubmed.ncbi.nlm.nih.gov/21109690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conventional and molecular cytogenetic findings of myelodysplastic syndrome patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21109690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonal karyotype evolution involving ring chromosome 1 with myelodysplastic syndrome subtype RAEB-t progressing into acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21109690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorescence in situ hybridization using the subtelomeric 11q probe as a diagnostic tool for congenital thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21109690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21109690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21109690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21109690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorescence in situ hybridization testing for -5/5q, -7/7q, +8, and del(20q) in primary myelodysplastic syndrome correlates with conventional cytogenetics in the setting of an adequate study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21109690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2010.026658

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41854078&oldid=1928907235"